Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Bangsberg

Showing results (151-160 of 390) with videos related to

Pageof 39
Sort By:
AIDS (London, England)|January 28, 2006
Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohortPaula Braitstein, Amy Justice, David R Bangsberg, et al.
Current HIV/AIDS Reports|October 13, 2006
The potential impact of antiretroviral therapy on fertility in sub-Saharan AfricaAngela Kaida, Irene Andia, Marissa Maier, et al.
Plos One|July 30, 2013
Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern UgandaAnnet Kembabazi, Francis Bajunirwe, Peter W Hunt, et al.
AIDS and Behavior|July 2, 2017
Reliability, Validity, and Factor Structure of the Hopkins Symptom Checklist-25: Population-Based Study of Persons Living with HIV in Rural UgandaScholastic Ashaba, Bernard Kakuhikire, Dagmar Vořechovská, et al.
AIDS (London, England)|January 26, 2016
The Meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural UgandaNorma C Ware, Emily E Pisarski, Melanie Tam, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 15, 2010
Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence levelViviane D Lima, David R Bangsberg, P Richard Harrigan, et al.
AIDS and Behavior|March 31, 2011
Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptableJessica E Haberer, Gregory K Robbins, Michele Ybarra, et al.
BMC Research Notes|March 21, 2012
Potential for false positive HIV test results with the serial rapid HIV testing algorithmSteven Baveewo, Moses R Kamya, Harriet Mayanja-Kizza, et al.
AIDS Care|September 4, 2016
Does substance use compromise depression treatment in persons with HIV? Findings from a randomized controlled trialDavid J Grelotti, Gwendolyn P Hammer, James W Dilley, et al.
American Journal of Respiratory and Critical Care Medicine|January 16, 2007
Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individualsAnnie F Luetkemeyer, Edwin D Charlebois, Laura L Flores, et al.
Pageof 39

Showing results (151-160 of 390) with videos related to

Sort By:
Pageof 39
AIDS (London, England)|January 28, 2006
Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohortPaula Braitstein, Amy Justice, David R Bangsberg, et al.
Current HIV/AIDS Reports|October 13, 2006
The potential impact of antiretroviral therapy on fertility in sub-Saharan AfricaAngela Kaida, Irene Andia, Marissa Maier, et al.
Plos One|July 30, 2013
Disinhibition in risky sexual behavior in men, but not women, during four years of antiretroviral therapy in rural, southwestern UgandaAnnet Kembabazi, Francis Bajunirwe, Peter W Hunt, et al.
AIDS and Behavior|July 2, 2017
Reliability, Validity, and Factor Structure of the Hopkins Symptom Checklist-25: Population-Based Study of Persons Living with HIV in Rural UgandaScholastic Ashaba, Bernard Kakuhikire, Dagmar Vořechovská, et al.
AIDS (London, England)|January 26, 2016
The Meanings in the messages: how SMS reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural UgandaNorma C Ware, Emily E Pisarski, Melanie Tam, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 15, 2010
Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence levelViviane D Lima, David R Bangsberg, P Richard Harrigan, et al.
AIDS and Behavior|March 31, 2011
Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptableJessica E Haberer, Gregory K Robbins, Michele Ybarra, et al.
BMC Research Notes|March 21, 2012
Potential for false positive HIV test results with the serial rapid HIV testing algorithmSteven Baveewo, Moses R Kamya, Harriet Mayanja-Kizza, et al.
AIDS Care|September 4, 2016
Does substance use compromise depression treatment in persons with HIV? Findings from a randomized controlled trialDavid J Grelotti, Gwendolyn P Hammer, James W Dilley, et al.
American Journal of Respiratory and Critical Care Medicine|January 16, 2007
Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individualsAnnie F Luetkemeyer, Edwin D Charlebois, Laura L Flores, et al.
Pageof 39